Bio-Path Holdings Announces Clearance of Investigational New Drug Application for BP1002 in Refractory/Relapsed Acute Myeloid Leukemia Patients

NEXT STORY
Yamana Gold Repurchases an Additional 1,584,500 Common Shares Under Its Share Repurchase Program for a Cumulative Total of 3,321,276 Common Shares for Approximately C$18 Million
PREV STORY
Functional Dyspepsia – Epidemiology Forecast to 2030
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

PacBio’s SMRT Sequencing Provides Unprecedented Insight into Genome of Disease-causing Mosquito

Improved Reference Genome for Aedes aegypti, Carrier of Zika Virus and Other Public Health ...

author_avatar
NASDAQ Market News

Arthroscopic Shavers (Orthopedic Devices) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

author_avatar
NASDAQ Market News

Ascendis Pharma A/S Announces Proposed Public Offering of ADSs

author_avatar
NASDAQ Market News